Jacek Mokrosinski

Company: Novo Nordisk

Job title: Senior Scientist

Seminars:

Unveiling Effective Strategies to Enhance GLP-1 Tolerability 8:30 am

Highlighting cutting-edge treatment combinations aimed at improving tolerability to enhance patient benefit Exploring case studies showcasing the correlation between enhanced tolerability and improved adherence to treatment plans Paving the way for future improvements by generating innovative ideas to optimize tolerability in GLP-1 therapeutic interventionsRead more

day: Conference Day Two

Panel Discussion: Exploring the Therapeutic Potential of GLP-1s – Assessing New Indicative Benefits & Their Association with Weight Loss 3:00 pm

Evaluating the impact of GLP-1s: are all observed benefits attributable to weight reduction or are other mechanisms in play? Considering how co-morbidities should be addressed from a clinical and commercial strategy perspective Clarifying uncertainties related to expanding into numerous new therapeutic areasRead more

day: Conference Day One